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Abstract
The cervicovaginal fluid (CVF) coating the vaginal epithelium is an important immunological
mediator, providing a barrier to infection. Glycosylation of CVF proteins, such as mucins,
IgG and S-IgA, plays a critical role in their immunological functions. Although multiple fac-
tors, such as hormones and microflora, may influence glycosylation of the CVF, few studies
have examined their impact on this important immunological fluid. Herein we analyzed the
glycosylation of cervicovaginal lavage (CVL) samples collected from 165 women under
different hormonal conditions including: (1) no contraceptive, post-menopausal, (2) no
contraceptive, days 1-14 of the menstrual cycle, (3) no contraceptive, days 15-28 of the
menstrual cycle, (4) combined-oral contraceptive pills for at least 6 months, (5) depo-
medroxyprogesterone acetate (Depo-Provera) injections for at least 6 months, (6) levonor-
gestrel IUD for at least 1 month. Glycomic profiling was obtained using our lectin microarray
system, a rapid method to analyze carbohydrate composition. Although some small effects
were observed due to hormone levels, the major influence on the glycome was the pres-
ence of an altered bacterial cohort due to bacterial vaginosis (BV). Compared to normal
women, samples from women with BV contained lower levels of sialic acid and high-man-
nose glycans in their CVL. The change in high mannose levels was unexpected and may be
related to the increased risk of HIV-infection observed in women with BV, as high mannose
receptors are a viral entry pathway. Changes in the glycome were also observed with hor-
monal contraceptive use, in a contraceptive-dependent manner. Overall, microflora had a
greater impact on the glycome than hormonal levels, and both of these effects should be
more closely examined in future studies given the importance of glycans in the innate
immune system.
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Introduction
The mucosal lining of the female genital tract provides a robust barrier to infection from patho-
gens such as HIV-1 [1, 2]. Cervical mucus, a natural hydrogel consisting predominantly of
water (95%-98%) and large and structurally complex mucin glycoproteins (2%-5%), is secreted
into the vagina providing lubrication and a natural barrier to microorganisms and viruses [3–
6]. Cervicovaginal fluid (CVF) contains this mucus along with an assortment of other anti-mi-
crobial glycoproteins including S-IgA, IgG, cathepsin G, lysozyme and lactoferrin [7–11]. Gly-
cosylation of proteins in the CVF influence their stability, activity and function [12]. For
example, mannose structures on S-IgA in vaginal fluid act as an alternative ligand for uro-
pathogenic type-1 Escherichia Coli inhibiting vaginal colonization and subsequent urinary
tract infection[13]. Thus, glycosylation plays an important role in the anti-microbial properties
of the CVF.
Multiple factors may influence the glycomic composition of the CVF including hormones
and vaginal microflora. Oral contraceptives have been shown to regulate the glycosylation of
serum glycoproteins such as α1-acid glycoprotein [14]. In one of the only studies on the CVF
glycome, changes in sialylation were observed in cervical mucin O-glycans at ovulation. How-
ever, few differences were observed at other time points [3]. Microflora may also play a role in
CVF glycome composition. Women with bacterial vaginosis (BV), in which the balance be-
tween Lactobacillus species and competing anaerobic bacteria shifts towards the anaerobes
[15], display high levels of vaginal sialidase, first reported by Briselden et al. [16, 17]. These en-
zymes cleave the negatively charged sugar sialic acid from terminal glycans of glycoproteins in
the CVF, changing the glycan composition of the CVF and increasing proteolysis of innate im-
mune factors such as S-IgA and lactoferrin [18].
To date, no systematic study has examined the effects of exogenous hormones and microflo-
ra on the vaginal glycome. Herein, we utilize lectin microarrays [19, 20], our high-throughput
glycomic analysis platform, to profile the glycosylation patterns of cervicovaginal lavage (CVL)
samples from 169 women. The sample cohort includes women on different hormonal contra-
ceptives and with different microflora. Lectin microarrays, in which carbohydrate binding
proteins are arrayed, are a versatile glycomic platform that has been used to analyze the glyco-
sylation of samples from bacteria to human cancer tissues [21–26]. Our lectin microarray data
demonstrates that while both exogenous hormones and microflora affect the glycome, the
strong impact of microflora on the glycome, confounds assessment of hormonal effects. De-
creased high mannose levels were observed in the CVL of women with BV, which may increase
susceptibility to other pathogens. This study sets the stage for more detailed analysis of the ef-
fects of both hormone and individual microbes on the glycome of vaginal fluids and its func-
tion in innate immunity against pathogens.
Materials and Methods
Study Population
Following Institutional Review Board approval by the University of Pittsburgh
(#PRO11020218), written informed consent was obtained from subjects enrolled in our study.
Women were excluded if: they were breastfeeding or pregnant; presented vaginal symptoms;
had a hysterectomy; had been diagnosed with any cervical or vaginal infections or had used
any antimicrobials in the past 14 days; had used any vaginal devices or vaginally-applied prod-
ucts (excluding tampons) in the past week. Upon enrollment the women had: an OraQuick ad-
vance rapid HIV test; a pregnancy test; their demographic information was recorded; height
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and weight taken and medical, gynecologic and sexual histories taken. Cervicovaginal lavage
(CVL) was collected from 169 women. 4 of 169 samples were excluded.
These women were characterized into six groups: (1) post-menopausal; (2) not contracept-
ing on days 1–14 of the menstrual cycle; (3) not contracepting on days 15–28 of the menstrual
cycle; (4) combined oral contraceptive; (5) DMPA (medroxyprogesterone acetate, Depopro-
vera); and (6) Mirena IUD (levonogerestrol Intrauterine Device) usage. These data were also
stratified according to microflora status using the Nugent score [27].
Sample Collection
First a vaginal swab was taken for a Gram Stain evaluation for microflora status using the
Nugent method of scoring [27]. Cervicovaginal lavage specimens (CVL) were collected in 10
mL of normal saline (Hospira, Inc. Lake Forest, IL). The saline and a syringe were used to gent-
ly wash the cervix and vaginal vault. The CVL was collected and placed in a 15 mL plastic cen-
trifuge tube and stored at 4°C until processing. Within one hour the samples were transported
to the laboratory. Upon receipt in the laboratory, CVLs were dispensed into 2 mL cryovials. All
samples were stored at -80°C.
Sample labeling
The CVL samples (100 μg protein based on Lowry) were labeled with NHS-Cy5 dye (6 μg GE
Healthcare Life Sciences, Piscataway, NJ) in 100 mMNaHCO3 buffer, pH 9.3. A pooled sample
of the CVL was labeled with NHS-Cy3 dye (60 μg per mg of protein) for use as the reference.
Samples were incubated for 45 min at room temperature with gentle shaking to allow labeling
and the free dye was then quenched by addition of 2 M Tris buffer, pH 6.8 (final concentration
250 mM). Samples were then dialyzed overnight against PBS at 4°C using a Microdialyzer
(3,000 MWmembrane, Spectrum Laboratories). All the steps were performed in the dark. Pro-
tein concentrations of samples were obtained after dialysis using the microBCA assay (Pierce).
Lectin Microarray Analysis
Print conditions. Lectin microarrays were printed as previously described [20]. In brief,
92 lectins and antibodies (S1 Table) were kept on ice during preparation and transferred to
384-well microplates for printing. Samples were maintained at 12°C and printed on Nexterion
H slides (SCHOTT North America, Elmsford, NY) using a Nanoplotter 2.1 piezoelectric print-
er (GeSIM, Germany) with a pico-tip (Quantum analytics, Foster City, CA) at 45–50% humidi-
ty. Three spots per protein were printed in each of the 24 arrays per slide. After printing, slides
were incubated at RT for 2 hr to obtain maximum coupling to the NHS ester surface. The lec-
tins and antibodies, print concentrations and buffers are listed in S1 Table. Lectin microarrays
were tested for quality using Cy5-labeled glycoprotein standards (10 μg asialofetuin, fetuin and
RNase B).
Microarray hybridization. Printed slides were blocked with 25 mM ethanolamine in 100
mM sodium borate (pH 8.5) for 1 hr at RT in a coplin jar with gentle shaking. Slides were
washed 3 × with PBST (PBS with 0.005% Tween 20) and 1 × with PBS for 5 min each and then
dried using a slide spinner (Labnet International). An ArrayIt multi-well hybridization cassette
(Arrayit Corporation, Sunnyvale, CA) was used to create 24 distinct arrays for hybridization.
2.5 μg of Cy5-labeled CVL sample was incubated with equal amounts of Cy3-labeled reference
in 100 μl total volume PBST. Samples were added to each array and incubated for 2 h at RT
with gentle agitation. Sample solutions were then aspirated and slide chambers were washed
5 × with PBST (100 μL, 3 min, RT), followed by removal of the hybridization chamber and a
final wash with PBS (5 min in a coplin jar). The slide was spun-dry and scanned in the Cy3
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(ex/em 532/550–600 nm) and Cy5 (635/655–695 nm) channels with a Genepix 4300A slide
scanner (Molecular Devices, Sunnyvale, CA). Data were extracted using Genepix 7 (Molecular
Devices) and processed with Microsoft Excel 2011.
Microarray data analysis. The background-subtracted median fluorescence of the three
replicate spots per protein was tested for outliers using the Grubbs outlier test with α = 0.05.
The average value was determined for the three replicates after excluding the outliers if there
were any. The log2 values of the average signals were median-centered over the array in each
channel to account for differences in labeling efficiency [28]. The values obtained were log2 ra-
tios for each lectin or antibody. Hierarchical clustering of the processed data (S1 Data) was per-
formed using Pearson correlation coefficient with average linkage analysis by Cluster 3.0 [29]
and the data sets were visualized with Java Treeview [30]. We excluded from the analysis
probes whose average signal was not higher than the median of the array for at least of 10% of
samples as these were considered inactive. This resulted in the exclusion of 22 lectins from fur-
ther analysis. Lilliefors test [31–33] was used to test the normality for sample distributions.
Data was considered normal by this standard. P values were calculated with one-way ANOVA
[34]. All the box plots were made with Matlab 2013a.
Results and Discussions
Study Design
Cervicovaginal lavage (CVL) samples, which represent a comprehensive collection of fluid and
mucus from the lower reproductive tract [35], were collected from 169 women under different
hormonal and reproductive conditions including: (1) post-menopausal, 29 women; (2) days
1–14 of the menstrual cycle, 27 women; (3) days 15–28 of the menstrual cycle, 26 women; (4)
combined oral contraceptive for at least 6 months, 27 women; (5) depo-medroxyprogesterone
acetate (Depo-Provera) injections for at least 6 months, 28 women; (6) levonorgestrel Intra-
uterine Device (IUD) usage for at least 1 month, 28 women [36]. Women in groups 1–3 were
free of hormonal contraceptives. Four of the 169 samples were excluded from further analysis
due to failure to meet the inclusion criterion. One sample was excluded due to Chlamydia tra-
chomatis. The other three samples were excluded because three women participated in the
sample collection protocol for two different periods of the same menstrual cycle, i.e. their
samples were collected for groups 2 and 3. The vaginal microflora of study participants was
evaluated using the Nugent scoring system to determine bacterial vaginosis (BV) status [27].
Normal microflora was defined as a Nugent score of 0–3, intermediate: 4–6 and BV: 7–10. In a
recent study, the Nugent score was found to accurately reflect shifts in the microflora composi-
tion of the vagina [15]. The Nugent score is validated only for use among women of reproduc-
tive age, so it does not apply to postmenopausal women [27]. Consequently postmenopausal
women were excluded from our comparative analysis of Normal and BV samples.
Lectin Microarray Analysis of the CVL
In lectin microarray analysis, we label the glycoproteins in our samples with Cy5-dye through
lysine coupling to the corresponding NHS-ester. The labeled glycoproteins are then mixed
with a Cy3-labeled biological reference and incubated with our microarrays to obtain a semi-
quantitative dual-color analysis that is accurate for relative glycomic composition (Fig 1A)
[37–39]. Cervical vaginal lavage fluid is known to contain large amounts of free sugars, mainly
glucose, mannose and glucosamine [7]. As high concentrations of these monosaccharides can
inhibit lectins, such as those on our microarrays, we tested whether dialysis of labeled CVL
samples would alter the resulting microarray profiles. In initial studies, we observed lower sig-
nals for some lectins in undialyzed samples presumably due to free sugar content, thus we
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dialyzed all CVL samples post-labeling using a low molecular weigh cutoff (3 kD, S1 Fig). For
our analysis, we combined 2.5 μg of Cy5-labeled CVL sample with equal amounts of a Cy3-la-
beled pooled reference created from all samples and analyzed them on our lectin microarrays.
Median-centered log2 (sample/reference) ratios were calculated after data extraction. Normal-
ized data was then hierarchically clustered using the Pearson correlation coefficient as the dis-
tance metric and average linkage analysis to generate the heatmap shown in Fig 1B.
Initial examination of the heatmap suggested that both microbial status and hormonal levels
impact the glycome. Samples most clearly segregated by microbial status (Fig 1C). This pattern
was established by three sets of lectins: β-galactose (Gal)/ β-N-acetyl-D-galactosamine (Gal-
NAc) (AIA, ECA, RCA, a list of lectin abbreviations and rough specificities is shown in S1
Table), high mannose (CVN, UDA, SVN, GRFT) and α2, 6-sialic acid binders (TJA-I and
SNA). In contrast, a clear pattern was difficult to discern for hormonal regulation, although
some clustering was observed for postmenopausal women (PM) and women on Depo-Provera
(Depo). Microbial status interfered with our assessment of the role that hormones play in es-
tablishing the CVL glycome. We observed two distinct Depo clusters (one with BV and one
without) with different glycan profiles in our large dataset (Fig 1C), arguing that microbial sta-
tus may predominate over hormones in the control of glycosylation. We cannot address the
microbial status of the postmenopausal women in this study, so conclusions on the role of hor-
mone and/or microbial status on glycosylation in that cohort are not possible, thus we excluded
these samples from further analysis. Based on our findings, we undertook a more detailed
Fig 1. Lectin Microarray Analysis of CVL. (A) Experimental scheme. Equal amounts of Cy5-CVL sample and Cy3-pooled CVL reference were analyzed on
the lectin microarray. (B) Heat map of hierarchical clustering. Median-normalized log2 ratios (Sample (S) /Reference (R)) of 165 CVL samples were
hierarchically clustered using Pearson correlation coefficient as the distance metric and average linkage analysis (yellow, log2(S) > log2(R); blue, log2(R) >
log2(S)). Samples are color coded by hormonal and microbial status across the top: Postmenopausal (orange), Days 1–14 (black), Days 15–28 (light teal),
Oral contraceptive (purple), Depo-Provera (gray), IUD (pink), BV (green), Intermediate (dark teal), Normal (blue). (C) Select sample and lectin clusters
showing BV vs. Normal patterns. Pearson correlation coefficient scale is shown.
doi:10.1371/journal.pone.0127021.g001
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statistical analysis of our data to better define the roles of microbial status (BV/normal) and
hormones on specific glycosylation signatures in the CVL.
Bacterial Vaginosis has a Strong Effect on Glycosylation in the CVL
To more closely examine the effects of bacterial vaginosis (BV) on CVL glycosylation in this
cohort, we performed ANOVA analysis on a combined cohort of BV (n = 23), intermediate
(n = 23) and normal (n = 90) samples, disregarding hormonal status, for each lectin on our micro-
array. In line with our earlier findings, we observed statistically significant decreases in lectins cor-
responding to α2,6-sialic acid, and high mannose epitopes and an increase in β-Gal, β-GalNAc
binding (Figs 2 and 3). We tested whether hormonal differences in the cohorts could account for
these changes as we had a predominance of 2 groups within the BV cohort (days 1–14 of the men-
strual cycle and Depo-Provera, n = 8 each, 35% each of cohort). Normal samples from the days
1–14 and Depo-Provera groups did not follow the trends observed in BV (S2 Fig). In addition,
comparison of normal vs. BV samples within the each group demonstrated similar effects on the
glycome due to aberrant microflora seen in the combined cohort (i.e. decreases in α2,6-sialic acid
and high mannose) arguing that the microbiome overrides hormonal effects (S3 and S4 Figs).
Several of these changes are consistent with the known biological effects of BV on the gly-
come of the vagina. In bacterial vaginosis higher levels of sialidase, an enzyme that cleaves sialic
acid molecules from underlying β-Gal and β-GalNAc structures, are observed [6, 16]. In a com-
panion paper, Moncla et al. show higher levels of sialidase activity correlated with BV in these
CVL samples. This would cause a loss of sialic acids and an increase in exposed terminal β-Gal
and β-GalNAc residues (Fig 2A and 2F). In our data we observed the loss of α2, 6-sialic acid
residues (p< 0.0001 for both SNA [40] and TJA-I [41], Fig 2B and 2C) and the gain of terminal
β-Gal and β-GalNAc structures (β-Gal: ECA [42] and RCA [43], p< 0.0001 for both, Fig 2D
and 2E; β-GalNAc: AIA [44] and MNA-G [45], p< 0.0001 for both, Fig 2G and 2H). We also
observed an effect of BV on levels of α2, 3-sialic acid as probed byMaackia amuerensis lectin-I
(MAL-I) binding but the effect is not statistically significant (p = 0.4). Similar results for SNA
andMaackia amuerensis lectin were observed by enzyme-linked lectin assays (see the accom-
panying paper by Moncla et al., PONE-D-15-01714). This more mild effect on MAL-I binding
may be due to the strong binding of MAL-I to sulfated glycans, which are present in CVL but
are not affected by sialidase [3, 46, 47] (S5 Fig). We also observed a gain in binding to terminal
β-Gal and β-GalNAc residues, consistent with their exposure by sialidase (Fig 2D, 2E, 2G and
2H). This increase is observed in both the N-linked (ECA, RCA) and O-linked (AIA, MNA-G)
cohorts and is clear even in intermediate samples where the changes in sialic acid are not readi-
ly apparent. Levels of α-GalNAc, however, were unaffected by BV (HPA, S6 Fig).
Our data also shows a loss of high mannose residues on glycoproteins of the CVL from
women with BV (Fig 3). High-mannose glycans can contain five to nine mannose residues at-
tached to the chitobiose (GlcNAc2) core and are early products of N-glycan biosynthesis. We
observed a significant loss of binding to two algal lectins, Griffithsin (GRFT) and Scytovirin
(SVN), which are both specific to Man7-Man9 high mannose structures, in the BV cohort (Fig
3 B and C, p< 0.0001 and p = 0.0002, respectively). This data is supported by work by Moncla
et al. (see accompanying paper). Both of these proteins are known anti-viral lectins and are cur-
rently being examined for use as microbicides against viruses including HIV-1 and hepatitis-C
[48–50]. We do not observe statistically significant differences with other mannose-binding
lectins, such as AMA, ASA [51], ConA [52], GNA and NPA [53] (S7 Fig), which can also bind
Man5-Man6, suggesting that this loss is restricted to the Man7-Man9 subset.
Previous studies have shown that both HIV infection risk and urinary tract infection risk in-
crease with bacterial vaginosis [54–57]. High mannose residues on S-IgA have been proposed to
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Fig 2. Effects of vaginal microflora on sialylation. (A) RepresentativeN-linked glycan before and after sialidase digestion. Lectin binding determinants are
shaded in grey with lectin names indicated. (B-E) Notched boxplot representation of binding levels of (B) SNA, (C) TJA-I, (D) ECA, (E) RCA to Normal,
Intermediate and BV sample cohorts. (F) RepresentativeO-linked glycans before and after sialidase. (G-H) Notched boxplot representation of binding
levels of (G) AIA and (H) MNA-G. For all plots, significance levels between groups indicated by lines are as follows: *, 0.01< p0.05; **, 0.001< p0.01;
***, 0.0001<p0.001; ****, p0.0001. Outliers are marked in red.
doi:10.1371/journal.pone.0127021.g002
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act as a natural inhibitor of urinary tract infections by inhibiting Escherichia coli expressing
FimH, a bacterial lectin specific for high mannose, to vaginal epithelia [58, 59]. High mannose
epitopes found on the gp120 coat protein of HIV-1 bind to endogenous lectins DC-SIGN and
the macrophage mannose receptor (MMR) and aid in the infection of macrophages and dendrit-
ic cells [60, 61]. Binding of vaginal MMR by gp120 on HIV-1 may also play a role in sexual
transmission of HIV-1 [62]. Native high mannose residues found on glycoproteins in vaginal
fluids may thus act as natural inhibitors of these pathogenic interactions, helping to prevent viral
entry and bacterial adhesion in women with normal microflora. The alteration in high mannose
levels associated with abnormal microflora may alter the innate immune properties of the vagi-
nal mucosa enabling enhanced pathogenesis in concordance with the increased infection risk.
Exogenous Hormones Influence the Glycome
We reanalyzed our lectin microarray data for hormonal effects, examining the data for the 90
women with normal microflora. We excluded postmenopausal women, as we could not evalu-
ate the status of their microbiome. We examined the effects of normal hormonal status on the
CVL glycome by comparing women in days 1–14 of their menstrual cycle to women in days
15–28. We observed several changes associated with the menstrual cycle including a loss of
GRFT binding in the later stages (p = 0.036, Fig 4), which is consistent with analysis in the
companion paper by Moncla et al. To examine the effects of exogenous hormone contracep-
tives on glycomic composition of the CVL, we combined women in menstrual cycle without
contraceptives (No HC, n = 31, Fig 5) and compared them to contraceptive users (HC Users,
Fig 3. Effects of vaginal microflora on highmannose. (A) High mannose glycan structure. Lectin binding determinants are shaded in grey. (B-C)
Notched boxplot representation of binding levels of (B) GRFT and (C) SVN. Significance: *, 0.01< p0.05; **, 0.001< p0.01; ***, 0.0001<p0.001;
****, p0.0001. Outliers are in marked red.
doi:10.1371/journal.pone.0127021.g003
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Fig 4. Effects of menstrual cycle on glycosylation of CVL. (A) Bi-plot of lectin microarray data for CVL from women in days 1–14 (x-axis) versus days 15–
28 (y-axis). Graph shows average data for each lectin. Lectins and antibodies showing significant differences (p < 0.05) between the two groups are labeled
with diamonds. Lectins with similar binding glycans are labeled in the same color (yellow: Gal/GalNAc; green: high mannose; purple: sialyl Lewis A). Lectins
above the red dashed line showed increased expression levels during days 15–28 of the menstrual cycle compared to days 1–14. (B) Visual representation
of glycans showing significant differences between the two groups.
doi:10.1371/journal.pone.0127021.g004
Analysis of Effects of Hormones and Microbiome on Vaginal Glycome
PLOSONE | DOI:10.1371/journal.pone.0127021 May 20, 2015 9 / 16
Fig 5. Effects of exogenous hormones on CVL glycome. (A) Representative N-linked complex glycan with bisecting GlcNAc. Lectin binding epitopes are
shaded in grey. (B-C) Notched boxplot representation of binding levels of (B) PHA-E and (C) RCA for women on no hormonal contraceptives (No HC) or on
hormonal contraceptives (HC). (D-G) Notched boxplot representation of detailed analysis of binding of (D) PHA-E, (E) RCA, (F) Calsepa and (G) ECA for
women on oral contraceptives (Oral), Depo-Provera (Depo) or IUD in comparison to the No HC cohort. Significance: *, 0.01< p0.05; **, 0.001< p0.01;
***, 0.0001<p0.001; ****, p0.0001. Outliers are marked in red.
doi:10.1371/journal.pone.0127021.g005
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n = 59). Only two lectins gave statistically significant differences in signal for the cohorts.
PHA-E, which binds to N-linked glycans containing bisecting GlcNAc [63], and RCA, which
binds terminal galactose, both showed decreased binding to the CVL of contraceptive users
(Fig 5A–5C, p = 0.046 and p = 0.002 respectively). We next ran a more detailed analysis, look-
ing at the contribution of individual contraceptive cohorts (Oral, Depo-Provera and IUD) to
the differences observed. All three contraceptive methods contain different synthetic hor-
mones; combined oral contraceptives have estrogen and progesterone, Depo-Provera contains
depo-medroxyprogesterone acetate, a progesterone derivative, and the IUD contains a different
progesterone derivative, levonorgestrel. Depo-Provera users showed significantly lower levels of
bisecting GlcNAc (PHA-E, Calsepa [64], Fig 5D and 5F, p = 0.0004 and p = 0.007 respectively)
and terminal galactose (RCA, ECA, Fig 5E and 5G, p = 0.0009 and p = 0.004, respectively) than
other contraceptive users and were the major contributor to the pattern observed for contracep-
tive use. In recent studies bisecting GlcNAc epitopes were found to enhance binding of IgG Fc
to the FcγIIIa receptor leading to antibody-dependent cellular cytotoxicity [65]. Decrease in this
epitope would presumably lower the levels of antibody-dependent immune response. This is
consistent with recent work showing an anti-inflammatory effect by Depo-Provera on endocer-
vical cells [66]. Oral contraceptive users also showed some glycomic changes in comparison to
non-users, although the effects were less significant (0.01< p< 0.05) and a clear glycomic pat-
tern did not emerge. IUD users showed no real changes compared to the no-HC group. Our
data suggests that both hormonal contraceptive composition and delivery method impact the
vaginal glycome in ways that may affect immunity.
Conclusions
The glycome of fluids from the cervico-vaginal tract plays an important role in the innate im-
mune system, preventing pathogenic interactions and modulating immune activation. The
study described herein and the accompanying work by Moncla et al (PONE-D-15-01714),
which use cervical vaginal lavage samples (CVL) to represent the fluid and mucus from the
lower reproductive tract, are the first to examine the role of hormonal contraceptives and mi-
croflora on glycosylation in this critical immunological fluid. Our data demonstrates that
pathogenic microflora, such as that observed in bacterial vaginosis, have a profound effect on
the CVL glycome overriding hormonal effects. These alterations may lower the immunologi-
cal function of the cervico-vaginal fluids, enhancing the ability of secondary pathogens, such
as HIV-1, to infect the host. Hormonal contraceptives also alter this glycome, with currently
unknown implications. Both the route of contraceptive administration and the type of syn-
thetic hormone used may play a role in these changes. These differences point out the need
for further paired-patient studies examining the direct effects of different hormonal contra-
ception agents on the glycome and on the innate immune protection provided by cervico-
vaginal fluids.
Supporting Information
S1 Data. Processed Lectin Microarray Dataset used in analysis. Raw data is available at www.
synapse.org (doi:10.7303/syn3243404).
(XLSX)
S1 Fig. Lectin Microarray Comparison of Dialyzed and Undialyzed CVL. Lectin microarray
analysis of matched dialyzed and undialyzed Cy3-labeled samples. The fluorescence was inhib-
ited by free sugar in the CVL. Sample images are shown.
(TIFF)
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S2 Fig. Effect of hormones on glycans that change with BV. (A-H) Notched boxplot repre-
sentation of binding levels of (A) SNA, (B) TJA-I, (C) ECA, (D) RCA, (E) AIA, (F) MNA-G,
(G) GRFT and (H) SVN for women on no hormonal contraceptives (days 1–14 and 15–28)
and on hormonal contraceptives (oral contraceptives (Oral), Depo-Provera (Depo) or IUD).
Significance: , 0.01< p0.05; , 0.001< p0.01; , 0.0001<p0.001; , p0.0001. Out-
liers are marked in red. For all plots, significance levels between groups indicated by lines are as
follows: , 0.01< p0.05; , 0.001< p0.01; , 0.0001<p0.001; , p0.0001. Outliers
are marked in red. Differences due to hormone levels do not show the same general glycan pat-
terns as BV vs. non-BV.
(TIF)
S3 Fig. Effects of vaginal microflora on select glycans in women during days 1–14 of the
menstrual cycle. (A-H) Notched boxplot representation of binding levels of (A) SNA, (B)
TJA-I, (C) ECA, (D) RCA, (E) AIA, (F) MNA-G, (G) GRFT and (H) SVN for women at days
1–14 of the menstrual cycle with different flora states. The same effects caused by microflora
were observed in these women, matching the trends seen in combined cohorts. Significance:
, 0.01< p0.05; , 0.001< p0.01; , 0.0001<p0.001; , p0.0001. Outliers are
marked in red.
(TIF)
S4 Fig. Effects of vaginal microflora on select glycans in women on Depo-Provera. (A-H)
Notched boxplot representation of binding levels of (A) SNA, (B) TJA-I, (C) ECA, (D) RCA, (E)
AIA, (F) MNA-G, (G) GRFT and (H) SVN for women on Depo with different flora states. The
same effects caused by microflora were observed in these women, matching the trends seen in
combined cohorts. Significance: , 0.01< p0.05; , 0.001< p0.01; , 0.0001<p0.001;
, p0.0001. Outliers are marked in red.
(TIF)
S5 Fig. Effect of flora on levels of α2, 3-sialic acid as probed by MAL-I binding.Notched box-
plot representation of binding levels of MAL-I to normal, intermediate and BV samples is
shown. Outliers are marked red. The observed difference is not statistically significant (p = 0.4).
(TIFF)
S6 Fig. Effect of BV on HPA binding. Notched boxplot representation of binding levels for
HPA, a lectin that binds α-GalNAc, to normal, intermediate and BV samples is shown. None
of the differences were statistically significant. Outliers are marked red.
(TIF)
S7 Fig. Effect of BV on Lectins Binding Man5-Man6.Notched boxplot representation of
binding levels for lectins that bind Man5-Man6 to normal, intermediate and BV samples are
shown. (A) AMA, (B) ASA, (C) GNA, (D) NPA and (E) ConA. None of the differences were
statistically significant. Outliers are marked red.
(TIF)
S1 Table. Lectin Microarray Panel, Lectin Specificities and Print Conditions.
(DOCX)
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